The hemodynamic findings in five patients with congenital mitral stenosis, four of whom resided at mild altitude (5,200 to 6,500 feet) are presented. Pulmonary hypertension was present in all patients. Reactivity of tbe pulmonary vascular bpd was noted in the four patients residing at altitude. The administration of tolazoline and/or 100 percent 0 2 to three patients resulted in an average drop in mean pulmonary artery pressure (PAP) of 20 mm Hg (range 13 to 33) and in TPR of 790 dynes/M2 (range 350 to 1,200). In one patient catheterized 36 hours after being transferred to sea level mean PAP declined from 85 to 40 mm H g and TPR decreased from 1,590 to 730 dynes/M? These studies have shown the presence of markedly elevated TPR in patients with congenital mitral stenosis who reside at 5,200 feet. The pronounced reactivity of the pulmonary vascular bed with drugs and/or increase in oxygen tension suggests that reactive vasoconstriction, due m part to mild hypoxia, is an important factor in maintaining the high TPR in these patients.
ulmonary hypertension is present to variable Pdegrees in patients with mitral stenosis. Recent studies1-3 have shown that in subjects with some stimulus to maintain a reactive pulmonary vascular bed, such as pulmonary venous hypertension, the mild hypoxia of Denver may significantly affect the pulmonary circulation.
The purpose of this paper is to report the hemodynamic findings in five patients with congenital mitral stenosis, four of whom resided at mild altitude, 5200-6500 feet, and to show the effects of pulmonary arterial vasodilators on the pulmonary circulation in these patients. Between January, 1960 and January, 1968 , five cases of proved congenital mitral stenosis were evaluated at Colorado General Hospital. These five cases were not associated with the hypoplastic left heart syndrome or other similarly com- plex lesions. One of these patients had an associated patent ductus arteriosus ligated five months before the diagnosis of congenital mitral stenosis was made, thus converting the patient surgically into mitral stenosis. Serial clinical observations, electrocardiograms, and chest x-ray films were available for all patients. All patients underwent standard right heart catheterization and in four patients pulmonary angiography was performed. Three patients subsequently died and underwent postmortem examination. Four patients resided at mild altitude (5200-6500 ft) and one patient0 resided and was studied at low altitude.
The five patients ranged in age from 2 months to 12 years at the time the diagnosis of mitral stenosis was established. Presenting findings in the three infants (two to five months of age) were tachypnea, dyspnea, recurrent pulmonary infections, failure to thrive, and as symptomatology progressed, recurrent congestive heart failure. In the two older children ( 10 and 12 years of age), history of a heart murmur from a very young age was obtained,
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initially asymptomatic. In the one to two year period prior to diagnosis, however, symptoms of dyspnea on exertion and pulmonary congestion appeared and were progressive.
In the three younger children, the most frequently observed positive physical findings were secondary to the marked pulmonary hypertension present and the characteristic diastolic rumble of mitral stenosis did not appear in two of the children until after age one year. In both of these children only a very short diastolic murmur was noted and in one of them an associated murmur of tricuspid insufficiency was present. No opening snap was noted in the infants. In the two older children, both manifested signs of significant pulmonary hypertension, as well as the classic murmur of mitral stenosis with an opening snap present in each case.
Electrocardiographic abnormalities consisted of abnormal right axis deviation in four patients, right ventricular enlargement in four patients, and left atrial enlargement in four patients. Right atrial enlargement was also present in three patients with severe pulmonary hypertension. Standard chest films revealed left atrial enlargement and increased pulmonary vascular markings (venous) in all five patients. The main pulmonary artery was prominent in three patients and the right ventricle was prominent in three patients. Pulmonary artery angiography in four patients revealed left atrial enlargement and delayed left atrial emptying.
In the four patients residing at altitude, cardiac catheterization studies were performed in two patients between 7 and 18 months and in two patients at 10 and 12 years of age. In these patients, the resting mean pulmonary arterial wedge ( PAW ) pressures ranged from 18 to 24 mm Hg, mean pulmonary arterial pressures (PAP) ranged from 45 to 88 mm Hg; pulmonary arteriolar resistance (PAR) ranged from 570 to 2600 dynes/sec/ cm-V M2, and total pulmonary resistance ( TPR ) from 1095-3000 dynes/ M2. The cardiac index ( CI ) ranged from 2.5-3.6 L/min/ M2.
In contrast, in the one infant from low altitude, studied at three months of age, mean PA wedge pressure was 11 mm Hg, left atrial pressure was 1417 mm Hg, mean PA pressure 25 mm Hg, pulmonary arteriolar resistance ( PAR ) was 560 dynesIM2, and TPR 1000 dynes. The CI was 1.97 L/min/ M2.
One child, who resided at 5280 feet, was studied serially at ages 7 and 12 months, because of signs of increasing pulmonary hypertension and frequent m PAW = mean pulmonary arterial wedge pressure; iii PAP = mean pulmonary artery pressure; PAR =pulmonary arteriolar resistance; T P R = total pulmonary resistance; C I =cardiac index; ii SAP = mean systemic artery presuure.
episodes of congestive heart failure. Marked changes were noted in these studies (Table 1) . Whereas the mean PA wedge pressure had remained unchanged (18 rnm Hg), the mean PA pressure had increased from 45 to 88 mm Hg, PAR from 595 to 2600 dynes/M\ TPR from 1300 to 3000, and the CI had decreased from 3.5 to 2.5 L/min/M2. The mean systemic arterial pressure did not change significantly. The systemic arterial saturation was 91 percent at the first catheterization and had decreased to 84 percent at the time of the second catheterization.
Reactivity of the pulmonary vascular bed was determined by the administration of tolazoline 1 mg/ kg ( Priscoline ) and/or 100 percent oxygen at the time of right heart catheterization in three patients (Table 2 ) and by exercise in one patient. Following the administration of tolazoline ( 1 mg/ kg) and/or 100 percent oxygen there was an average drop in mean PA pressure of 20 mm Hg (range 13-33), in TPR of 790 dynes/M2 (350-1200 ) , and in PAR of 800 ( range 370-1250 ) . In one patient, the mean PA pressure was 50 mm Hg at rest and with moderate exercise increased to 80 mm Hg. These changes suggested the presence of reactive pulmonary vascular beds without advanced vascular changes.4
In one patient, pulmonary vascular reactivity was R =rest tol = tolazoline *tolazoline plus 100% oxygen evaluated in Denver with vasodilators and by transferring the subject to sea level3 (Table 3 ) . This patient, born with a patent ductus arteriosus and congenital mitral stenosis, underwent closure of his ductus at 13 months of age because of severe pulmonary hypertension. A reactive pulmonary vascular bed was noted prior to surgery, as shown by a fall in mean PA pressure from 69 to 53 mm Hg in association with a marked increase in pulmonary blood flow (2.8 to 5.5 L/min/ M ) after the administration of tolazoline. Following surgery, there was clinical evidence of increasing pulmonary hypertension and worsening of the patient's clinical status (by five months postoperation). It was thought that this was due to the combined stimuli of mitral stenosis plus the mild hypoxia of Denver. Thus, when this patient was studied again in Denver, following surgery, mean PA pressure was 71 ( 102146) mm Hg and the TPR was 1590 dynes/ M*. With the administration of tolazoline plus 100 percent oxygen, mean PA pressure decreased from 71 to 38 mm Hg, TPR decreased from 1590 to 770 dynes/ M* and the cardiac index rose modestly from 3.5 to 4.0 L/min. These studies suggested that the hypoxia of Denver was playing a significant role in maintaining the high pulmonary vascular resistance in this case.5 This was supported by studies obtained 36 hours after transferring the patient to Texas Children's Hospital (Houston), at sea level.
There it was shown that the mean PA pressure had decreased to 38 mm Hg (decrease of 34 mm Hg from the control Denver study) and the TPR had decreased to 730 dynes/ M2 (decrease of 860 from control Denver study). With the administration of 100 percent oxygen and tolazoline, there was a further decrease in mean PA pressure to 23 mm Hg and TPR decreased to 450 dynes/M*. The CI increased from a sea level control of 3.8 L/min/M2 before oxygen and tolazoline to 4.6 after the drugs were administered. With the administration of 15 percent oxygen there was a hyperreactive response to hypoxia, as mean PA pressure increased from 38 to 55 mm Hg.
These studies have demonstrated the presence of markedly increased PA pressure and total pulmonary resistance in patients with congenital mitral stenosis who reside at mild altitude (5200-6500 feet). Pronounced reactivity of the pulmonary vascular bed was noted following the administration of tolazoline and/or 100 percent oxygen or by increasing the ambient oxygen tension by moving a patient to sea level. This suggests that reactive vasoconstriction, due in part'to the mild hypoxia of altitude, is an important factor in maintaining the high TPR in these patients from mild altitude. 
